Edition:
India

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

261.82USD
11 Aug 2020
Change (% chg)

$3.92 (+1.52%)
Prev Close
$257.90
Open
$258.76
Day's High
$263.76
Day's Low
$257.50
Volume
78,313
Avg. Vol
94,956
52-wk High
$285.96
52-wk Low
$155.49

Select another date:

Tue, Jun 9 2020

BRIEF-Bio-Techne Continues To Expand Portfolio To Support SARS-CoV-2 And Covid-19 Research

* BIO-TECHNE CORP - CONTINUES TO EXPAND ITS PORTFOLIO TO SUPPORT SARS-COV-2 AND COVID-19 RESEARCH AND THERAPEUTIC DEVELOPMENT Source text for Eikon: Further company coverage:

BRIEF-Bio-Techne Announces Release Of GMP ProDots Proteins

* BIO-TECHNE ANNOUNCES RELEASE OF GMP PRODOTS PROTEINS TO SUPPORT CELL AND GENE THERAPY MANUFACTURING WORKFLOWS Source text for Eikon: Further company coverage:

BRIEF-Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of Covid-19 Serology Test

* BIO-TECHNE AND KANTARO BIOSCIENCES ANNOUNCE PARTNERSHIP TO DEVELOP AND SCALE PRODUCTION OF COVID-19 SEROLOGY TEST

BRIEF-Bio-Techne Releases Third Quarter Fiscal 2020 Results

* Q3 EARNINGS PER SHARE ESTIMATE $1.15 -- REFINITIV IBES DATA

BRIEF-Bio-Techne's Exosome Diagnostics Launches Exodx Prostate At-Home Collection Kit

* BIO-TECHNE'S EXOSOME DIAGNOSTICS LAUNCHES EXODX PROSTATE AT-HOME COLLECTION KIT Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Bio-Techne - General Services Administration Has Awarded Unlimited 10-Year Reimbursement Contract To Its Exosome Diagnostics Laboratory

* BIO-TECHNE CORP - GENERAL SERVICES ADMINISTRATION HAS AWARDED AN UNLIMITED 10-YEAR REIMBURSEMENT CONTRACT TO ITS EXOSOME DIAGNOSTICS LABORATORY Source text for Eikon: Further company coverage:

Select another date: